Cited by 236Ubiquitin and proteasome pathwaysImmune Response and InflammationNF-κB Signaling Pathways

Ubiquitin in the immune system

Open access
Zinngrebe, Julia, Montinaro, Antonella, Peltzer, Nieves, Walczak, Henning·2014·The EMBO Reports

Abstract

Ubiquitination is a post-translational modification process that has been implicated in the regulation of innate and adaptive immune responses. There is increasing evidence that both ubiquitination and its reversal, deubiquitination, play crucial roles not only during the development of the immune system but also in the orchestration of an immune response by ensuring the proper functioning of the different cell types that constitute the immune system. Here, we provide an overview of the latest discoveries in this field and discuss how they impact our understanding of the ubiquitin system in host defence mechanisms as well as self-tolerance.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/embr.201338025

Cites

210 of 210 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • This could be controlled by suppressing the development of auto-reactive immune cells through ubiquitination which is a degradative tag to be recognized by a proteasome complex such as PSMD7.

    “This could be controlled by suppressing the development of auto-reactive immune cells through ubiquitination which is a degradative tag to be recognized by a proteasome complex such as PSMD7 (Lodish et al., 2004; Zinngrebe et al., 2014).”

    From Identification of Candidate Signature Genes and Key Regulators Associated With Trypanotolerance in the Sheko Breed (2019) · cites this paper as Zinngrebe et al., 2014

    The ‘Ubiquitin in autoimmunity and autoinflammation’ section says ubiquitination is implicated in suppressing the development of autoreactive immune cells. The ‘Ubiquitin and ubiquitination’ section says some ubiquitin chains mark proteins for degradation, but the passages do not identify PSMD7 as the proteasome component involved or establish that degradation is the mechanism of that suppression. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 211 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

  1. [42]Kanayama A, Seth RB, Sun L, Ea CK, Hong M, Shaito A, Chiu YH, Deng L, Chen ZJ (2004) TAB 2 and TAB 3 activate the NF‐kappaB pathway through binding to polyubiquitin chains. Mol Cell 15: 535– 548 15327770
  2. [193]HogenEsch H, Torregrosa SE, Boggess D, Sundberg BA, Carroll J, Sundberg JP (2001) Increased expression of type 2 cytokines in chronic proliferative dermatitis (cpdm) mutant mice and resolution of inflammation following treatment with IL‐12. Eur J Immunol 31: 734– 742 11241277

Cited by

Sorted by citations

Authors
Zinngrebe, J., Montinaro, A., Peltzer, N., & Walczak, H.
Affiliations
University College London (GB)
Corresponding author
Walczak, Henning
Venue
The EMBO Reports
Published
2013-12-27
Volume
15
Issue
1
Pages
28-45
ISSN
  • 1469-221X (ISSN-L)
  • 1469-3178
OpenAlex
W2147973026
Cited by
227
References
211
Citations by year
2026: 8 · 2025: 16 · 2024: 21 · 2023: 27 · 2022: 21 · 2021: 22 · 2020: 14 · 2019: 14 · 2018: 16 · 2017: 16 · 2016: 25 · 2015: 15 · 2014: 11
FWCI
1.60
Type
journal article
Language
en
Update notices
erratum (2014-03-07)
Open access
Locations
  • EMBO Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
Funders
  • Boehringer Ingelheim Fonds
  • Swiss National Science Foundation
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
Keywords
ubiquitination, deubiquitination, ubiquitin system, innate immunity, adaptive immunity, immune system development, host defense, self-tolerance, post-translational modification
MeSH terms
Animals, Humans, Immunity, Innate, Tumor Necrosis Factor-alpha, Signal Transduction, Self Tolerance, Ubiquitin, Adaptor Proteins, Signal Transducing, Toll-Like Receptors, Ubiquitination, Host-Pathogen Interactions, Proteolysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review